Lithium mupirocin

• Catalog No.: 07188
• CAS Number: 73346-79-9
• M. F.: C26H43LiO9
• M. W.: 506.55522
• Purity: ≥95.0% (TLC)

SYNONYMS

• IUPAC name: lithium(1+) ion 9-({4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-{[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl}oxan-2-yl]-3-methylbut-2-enoyl}oxy)nonanoate
• IUPAC Traditional name: lithium(1+) ion 9-({4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-{[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl}oxan-2-yl]-3-methylbut-2-enoyl}oxy)nonanoate
• Synonyms: Pseudomonic acid A lithium salt; 9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid lithium salt

DATABASE IDS

• CAS Number: 73346-79-9
• MDL Number: MFCD11977847

PROPERTIES

• Empirical Formula (Hill Notation): C26H43LiO9
• Purity: ≥95.0% (TLC)
• Optical Rotation: [α]/D -21.0±2.0°, c = 1 in H2O
• Solubility: H2O: soluble10 mg/mL, clear, colorless
• Personal Protective Equipment: Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
• German water hazard class: 3

DETAILS

Description (English)

Application
Lithium mupirocin as been used to study mupirocin resistance in staphylococcus aureus 1 and in mycoplasma susceptibility studies 2.

Description (简体中文)

Application
Lithium mupirocin as been used to study mupirocin resistance in staphylococcus aureus 1 and in mycoplasma susceptibility studies 2.